The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

NZ sharemarket favours OCR cut, up 1.75%
Markets Market close

NZ sharemarket favours OCR cut, up 1.75%

The S&P/NZX 50 Index closed at 12,776.13, up 220.14 points or 1.75%.

Graham Skellern 09 Oct 2024
Cooks Coffee sales perk up
Markets

Cooks Coffee sales perk up

Sales were up 26% in the six months to September 29. 

Staff reporters 09 Oct 2024
Fast-track projects could inject energy into economy
Economy

Fast-track projects could inject energy into economy

A construction boost and lower interest rates could kickstart flagging activity.

Ian Llewellyn 09 Oct 2024
Vista board battle stokes 'culture clash' fears
Markets

Vista board battle stokes 'culture clash' fears

PE firm's hardball play to roll chair may galvanise opposition to its board quest.